News
Ionis Pharmaceuticals Inc. (NASDAQ:IONS) is one of the best mid cap pharma stocks to buy. On July 21, Ionis Pharmaceuticals announced that positive results from the Phase 3 OASISplus prospective ...
Global biotechnology leader CSL (ASX:CSL; USOTC:CSLLY) today announced that Health Canada has granted a marketing authorization for ANDEMBRY® (garadacimab) for routine prevention of attacks of ...
A real-world study published in the International Archives of Allergy and Immunology found that 3 years of lanadelumab ...
Patients with hereditary angioedema experienced fewer hospitalizations and ED and outpatient visits after beginning prophylactic treatment with berotralstat, according to a poster presented at a ...
If you have hereditary angioedema (HAE), getting an accurate diagnosis can be tricky. Because HAE is so rare, many doctors aren’t familiar with the disease. Also, your symptoms can mimic those ...
Angioedema of the upper respiratory tract can progress rapidly to life-threatening acute respiratory distress, airway obstruction, and death in the absence of appropriate pharmacologic ...
4d
Pharmaceutical Technology on MSNAstria Therapeutics licenses navenibart rights to Kaken for HAEAstria will receive $16m upfront and is eligible for a further $16m in commercialisation and sales milestones.
There are two kinds of hereditary angioedema (HAE) treatments: preventive and on-demand. Preventive Therapies Also known as prophylactic medication, this type of medication is taken regularly to ...
Background: Angioedema without major urticarial flares (hives) is poorly understood. Its causes are diverse, and little is known about its pathogenic mechanisms. We report on our 11 years of ...
BOSTON — Patients with hereditary angioedema saw significant reductions in attacks for 18 months after beginning berotralstat, according to two posters at the American College of Allergy, Asthma ...
Brandi Glanville has had a difficult two years due dealing with a mysterious medical condition that has caused facial ...
Researchers have shown that angioedema--a rare side effect with inhibitors of the renin-angiotensin-aldosterone system--appears to occur to a similar extent with aliskiren as with ACE inhibitors ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results